Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/1/4 申報
- 申報編號
- 0001968202-24-000025
- 申報時間
- 2024/1/4
- 交易日
- 2024/1/2
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 14 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $9.00 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/1/2 | Common Stock | S賣出處分 | −1 | $873.91 | −$873.91 | 18,446 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −2 | $886.26 | −$1,772.52 | 18,444 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −1 | $887.13 | −$887.13 | 18,443 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −1 | $892.00 | −$892 | 18,442 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −8 | $896.47F2 | −$7,171.76 | 18,434 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −3 | $897.41F3 | −$2,692.23 | 18,431 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −6 | $898.76F4 | −$5,392.56 | 18,425 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −14 | $899.66F5 | −$12,595.24 | 18,411 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −29 | $900.59F6 | −$26,117.11 | 18,382 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −9 | $901.46F7 | −$8,113.14 | 18,373 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −10 | $902.37F8 | −$9,023.7 | 18,363 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −13 | $903.49F9 | −$11,745.37 | 18,350 | 直接 | |
| 2024/1/2 | Common Stock | S賣出處分 | −3 | $904.49F10 | −$2,713.47 | 18,347 | 直接 | |
| 2024/1/2 | Common Stock | A公司授予取得 | +135 | $0.00 | $0 | 18,482 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/1/2 | Common Stock | A公司授予取得 | +1,607 | $0.00 | $0 | 1,607 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 8 shares of Company stock on January 2, 2024 at prices ranging from $896.21 to $896.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 3 shares of Company stock on January 2, 2024 at prices ranging from $897.35 to $897.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 6 shares of Company stock on January 2, 2024 at prices ranging from $898.45 to $898.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 14 shares of Company stock on January 2, 2024 at prices ranging from $899.08 to $899.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 29 shares of Company stock on January 2, 2024 at prices ranging from $900.00 to $900.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 9 shares of Company stock on January 2, 2024 at prices ranging from $901.03 to $901.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 10 shares of Company stock on January 2, 2024 at prices ranging from $902.14 to $902.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 13 shares of Company stock on January 2, 2024 at prices ranging from $903.13 to $903.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 3 shares of Company stock on January 2, 2024 at prices ranging from $904.00 to $904.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。